High mobility group nucleosome binding domain 1 pseudogene 16 (HMGN1P16)

High mobility group nucleosome binding domain 1 pseudogene 16 (HMGN1P16) is a human pseudogene formally cataloged under NCBI Gene ID 100874442. It is classified as a processed pseudogene, meaning it is a noncoding DNA segment derived from reverse-transcription and integration of an mRNA from the parent gene (high mobility group nucleosome binding domain 1, HMGN1). There is currently no evidence for functional protein product, regulatory role, disease association, nor indication of therapeutic targeting for HMGN1P16. While some high mobility group pseudogenes (such as HMGA1-p) have shown regulatory activity by affecting the stability of their parent gene’s mRNA[1][2], no such evidence exists for HMGN1P16, making this a pseudogene with no confirmed biological, pharmacological, or clinical relevance[3][4][7]. Key points: - This entry is not considered a receptor, drug target, biomarker, nor clinically relevant entity. - Its classification as a pseudogene means it is generally transcriptionally and translationally inactive, with rare exceptions in the human genome; no such exception is described for HMGN1P16. - No functional, structural, or disease data supports its use in therapeutic or biological research contexts at this time.

Other names

HMGN1P16high mobility group nucleosome binding domain 1 pseudogene 16

None; not a validated drug target